Roth/MKM analysts reinstated coverage on PLBY Group, Inc. (NASDAQ: PLBY) with a Buy rating and set a price target of $3.00, ...

Roth MKM re-initiated coverage of PLBY Group (PLBY) with a Buy rating and $3 price target The firm says that after “significant” strategic, ...

Roth MKM analyst Sean McGowan maintained a Buy rating on Flow Beverage Corp. (FLOW – Research Report) today and set a price target of C$2.00.

We recently compiled a list of the 10 AI News Updates Trending on Wall Street. In this article, we are going to take a look ...

Equities research analysts at Roth Capital cut their Q4 2024 EPS estimates for Viper Energy in a report released on Tuesday, January 28th. Roth Capital analyst L. Mariani now anticipates that the oil ...

Roth Mkm restated their buy rating on shares of TriSalus Life Sciences (NASDAQ:TLSI – Free Report) in a research report ...

Roth MKM keeps a Buy rating and $38 price target on Digi International (DGII) following its non-deal roadshow with the management team. The firm comes away from the discussions “cautiously ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 37.32% ...

Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...

Fintel reports that on December 18, 2024, Roth MKM initiated coverage of U.S. Gold (LSE:0LHW) with a Buy recommendation. As of December 3, 2024, the average one-year price target for U.S. Gold is ...

https://www.tipranks.com/news/the-fly/anavex-price-target-raised-to-42-from-40-at-h-c-wainwright Roth MKM lowered the firm’s price target on CervoMed (CRVO) to $4 ...